N-[(1S)-5-Amino-1-cyano-pentyl]-2-[(1R)-1-[2,5-dioxo-3-[4-(4-pyridyloxy)phenyl]imidazolidin-1-yl]ethyl]-3-methyl-benzimidazole-5-carboxamide

ID: ALA3799182

Chembl Id: CHEMBL3799182

PubChem CID: 127046555

Max Phase: Preclinical

Molecular Formula: C31H32N8O4

Molecular Weight: 580.65

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](c1nc2ccc(C(=O)N[C@H](C#N)CCCCN)cc2n1C)N1C(=O)CN(c2ccc(Oc3ccncc3)cc2)C1=O

Standard InChI:  InChI=1S/C31H32N8O4/c1-20(29-36-26-11-6-21(17-27(26)37(29)2)30(41)35-22(18-33)5-3-4-14-32)39-28(40)19-38(31(39)42)23-7-9-24(10-8-23)43-25-12-15-34-16-13-25/h6-13,15-17,20,22H,3-5,14,19,32H2,1-2H3,(H,35,41)/t20-,22+/m1/s1

Standard InChI Key:  YZQLWMPKABRHMP-IRLDBZIGSA-N

Alternative Forms

  1. Parent:

    ALA3799182

    ---

Associated Targets(Human)

PLAU Tchem Urokinase-type plasminogen activator (2016 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLG Tclin Plasminogen (2339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 580.65Molecular Weight (Monoisotopic): 580.2547AlogP: 4.04#Rotatable Bonds: 11
Polar Surface Area: 159.47Molecular Species: BASEHBA: 9HBD: 2
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.33CX Basic pKa: 10.20CX LogP: 1.86CX LogD: -0.76
Aromatic Rings: 4Heavy Atoms: 43QED Weighted: 0.20Np Likeness Score: -0.99

References

1. Teno N, Gohda K, Yamashita Y, Otsubo T, Yamaguchi M, Wanaka K, Tsuda Y..  (2016)  Plasmin inhibitors with hydrophobic amino acid-based linker between hydantoin moiety and benzimidazole scaffold enhance inhibitory activity.,  26  (9): [PMID:27009905] [10.1016/j.bmcl.2016.03.047]

Source